Cystic fibrosis (CF) is the second-most prevalent hereditary disease of child age in middle Europe. CF is characterized by thick mucus that clogs the airways. Symptoms of CF occur in several organs. Patients have a significantly impaired lung function. As an effect of good symptomatic treatment and unified medical care, life expectancy of patients suffering from CF has been raised significantly.
In collaboration with our DZL partners we started to investigate the effect of preventive treatment with inhaled hypertonic saline. Moreover, we want to study the course of the disease and new therapeutic options in a newborn screening.
11th DZL Annual Meeting, June 15th-16th, 2023 (Fürstenfeldbruck)
67th Meeting of ARCN